Paul A. Friedman, a director at Madrigal Pharmaceuticals, Inc. ($MDGL), sold common shares on the open market 77 times over the last 365 days, totaling $101.8 million. His most recent sale occurred on January 9, 2026. These $MDGL insider sales rank 161st among 11,678 individual insiders in our database, far exceeding the average sale value of $8.6 million across 6.4 transactions. Friedman made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 332 | $534.16 | 845,012.0000 | 22,711,420 | 0.04% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 280 | $530.69 | 845,424.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 166 | $529.76 | 845,704.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 691 | $529.17 | 845,870.0000 | 22,711,420 | 0.08% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 575 | $528.18 | 846,561.0000 | 22,711,420 | 0.07% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1560 | $526.97 | 847,136.0000 | 22,711,420 | 0.18% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1066 | $526.00 | 848,696.0000 | 22,711,420 | 0.13% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2432 | $525.05 | 849,762.0000 | 22,711,420 | 0.29% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1199 | $524.10 | 852,194.0000 | 22,711,420 | 0.14% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 970 | $523.00 | 853,393.0000 | 22,711,420 | 0.11% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 840 | $521.98 | 854,363.0000 | 22,711,420 | 0.10% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 681 | $521.03 | 855,203.0000 | 22,711,420 | 0.08% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 846 | $519.88 | 855,884.0000 | 22,711,420 | 0.10% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1363 | $518.68 | 856,730.0000 | 22,711,420 | 0.16% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2450 | $517.86 | 858,093.0000 | 22,711,420 | 0.28% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 766 | $516.84 | 860,543.0000 | 22,711,420 | 0.09% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1996 | $515.81 | 861,309.0000 | 22,711,420 | 0.23% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1345 | $514.68 | 863,305.0000 | 22,711,420 | 0.16% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1094 | $513.11 | 864,650.0000 | 22,711,420 | 0.13% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1480 | $511.98 | 865,744.0000 | 22,711,420 | 0.17% | 0.01% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 24520 | $15.80 | 867,224.0000 | 22,711,420 | 2.91% | 0.11% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 280 | $0.00 | 0.0000 | 22,711,420 | 100.00% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 280 | $551.24 | 842,704.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 280 | $15.80 | 842,984.0000 | 22,711,420 | 0.03% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 24520 | $0.00 | 280.0000 | 22,711,420 | 98.87% | 0.11% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 40 | $545.79 | 842,704.0000 | 22,711,420 | 0.00% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 600 | $540.36 | 842,744.0000 | 22,711,420 | 0.07% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 480 | $539.23 | 843,344.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 80 | $537.85 | 843,824.0000 | 22,711,420 | 0.01% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 487 | $536.88 | 843,904.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 473 | $536.02 | 844,391.0000 | 22,711,420 | 0.06% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 148 | $535.29 | 844,864.0000 | 22,711,420 | 0.02% | 0.00% |
| Jan. 9, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 80 | $532.50 | 845,344.0000 | 22,711,420 | 0.01% | 0.00% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 624 | $547.75 | 866,880.0000 | 22,711,420 | 0.07% | 0.00% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 24800 | $15.80 | 867,504.0000 | 22,711,420 | 2.94% | 0.11% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 24800 | $0.00 | 24,800.0000 | 22,711,420 | 50.00% | 0.11% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 160 | $555.39 | 842,704.0000 | 22,711,420 | 0.02% | 0.00% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1029 | $555.00 | 842,864.0000 | 22,711,420 | 0.12% | 0.00% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5001 | $553.83 | 843,893.0000 | 22,711,420 | 0.59% | 0.02% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5533 | $552.74 | 848,894.0000 | 22,711,420 | 0.65% | 0.02% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 7193 | $551.67 | 854,427.0000 | 22,711,420 | 0.83% | 0.03% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 4316 | $550.93 | 861,620.0000 | 22,711,420 | 0.50% | 0.02% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 409 | $549.99 | 865,936.0000 | 22,711,420 | 0.05% | 0.00% |
| Dec. 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 535 | $548.51 | 866,345.0000 | 22,711,420 | 0.06% | 0.00% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 600 | $359.81 | 842,704.0000 | 22,080,246 | 0.07% | 0.00% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 129172 | $9.45 | 971,876.0000 | 22,080,246 | 15.33% | 0.59% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1600 | $358.23 | 970,276.0000 | 22,080,246 | 0.16% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 455 | $359.31 | 969,821.0000 | 22,080,246 | 0.05% | 0.00% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 3153 | $360.27 | 966,668.0000 | 22,080,246 | 0.33% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1754 | $361.13 | 964,914.0000 | 22,080,246 | 0.18% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1439 | $362.29 | 963,475.0000 | 22,080,246 | 0.15% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2591 | $363.08 | 960,884.0000 | 22,080,246 | 0.27% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 3529 | $364.02 | 957,355.0000 | 22,080,246 | 0.37% | 0.02% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1716 | $365.19 | 955,639.0000 | 22,080,246 | 0.18% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 3152 | $366.22 | 952,487.0000 | 22,080,246 | 0.33% | 0.01% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 7119 | $367.31 | 945,368.0000 | 22,080,246 | 0.75% | 0.03% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 6788 | $368.34 | 938,580.0000 | 22,080,246 | 0.72% | 0.03% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 7992 | $369.44 | 930,588.0000 | 22,080,246 | 0.85% | 0.04% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 7877 | $370.44 | 922,711.0000 | 22,080,246 | 0.85% | 0.04% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 22710 | $371.53 | 900,001.0000 | 22,080,246 | 2.46% | 0.10% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 28976 | $372.39 | 871,025.0000 | 22,080,246 | 3.22% | 0.13% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 24166 | $373.35 | 846,859.0000 | 22,080,246 | 2.77% | 0.11% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 4155 | $374.38 | 842,704.0000 | 22,080,246 | 0.49% | 0.02% |
| Aug. 13, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 129172 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.59% |
| Aug. 11, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 3203 | $9.45 | 845,907.0000 | 22,080,246 | 0.38% | 0.01% |
| Aug. 11, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2903 | $350.19 | 843,004.0000 | 22,080,246 | 0.34% | 0.01% |
| Aug. 11, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 300 | $351.04 | 842,704.0000 | 22,080,246 | 0.04% | 0.00% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 43605 | $9.45 | 886,309.0000 | 22,080,246 | 5.17% | 0.20% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 3303 | $350.93 | 883,006.0000 | 22,080,246 | 0.37% | 0.01% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 3202 | $351.59 | 879,804.0000 | 22,080,246 | 0.36% | 0.01% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1382 | $352.61 | 878,422.0000 | 22,080,246 | 0.16% | 0.01% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 4768 | $354.06 | 873,654.0000 | 22,080,246 | 0.54% | 0.02% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 6546 | $355.00 | 867,108.0000 | 22,080,246 | 0.75% | 0.03% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5244 | $355.97 | 861,864.0000 | 22,080,246 | 0.60% | 0.02% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5094 | $356.94 | 856,770.0000 | 22,080,246 | 0.59% | 0.02% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 8434 | $357.93 | 848,336.0000 | 22,080,246 | 0.98% | 0.04% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5032 | $358.83 | 843,304.0000 | 22,080,246 | 0.59% | 0.02% |
| Aug. 11, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 3203 | $0.00 | 172,777.0000 | 22,080,246 | 1.82% | 0.01% |
| Aug. 12, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 43605 | $0.00 | 129,172.0000 | 22,080,246 | 25.24% | 0.20% |
| July 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 1400 | $9.45 | 844,104.0000 | 22,080,246 | 0.17% | 0.01% |
| July 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 1400 | $0.00 | 175,980.0000 | 22,080,246 | 0.79% | 0.01% |
| July 18, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1400 | $350.03 | 842,704.0000 | 22,080,246 | 0.17% | 0.01% |
| July 17, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 2700 | $0.00 | 177,380.0000 | 22,080,246 | 1.50% | 0.01% |
| July 17, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2000 | $350.10 | 843,404.0000 | 22,080,246 | 0.24% | 0.01% |
| July 17, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 700 | $351.57 | 842,704.0000 | 22,080,246 | 0.08% | 0.00% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 26176 | $0.00 | 180,080.0000 | 22,080,246 | 12.69% | 0.12% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 26176 | $9.45 | 868,880.0000 | 22,080,246 | 3.11% | 0.12% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5541 | $350.17 | 863,339.0000 | 22,080,246 | 0.64% | 0.03% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2371 | $351.38 | 860,968.0000 | 22,080,246 | 0.27% | 0.01% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2110 | $352.67 | 858,858.0000 | 22,080,246 | 0.25% | 0.01% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2319 | $353.82 | 856,539.0000 | 22,080,246 | 0.27% | 0.01% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 6851 | $354.65 | 849,688.0000 | 22,080,246 | 0.80% | 0.03% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5784 | $355.61 | 843,904.0000 | 22,080,246 | 0.68% | 0.03% |
| July 16, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1200 | $356.62 | 842,704.0000 | 22,080,246 | 0.14% | 0.01% |
| July 17, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 2700 | $9.45 | 845,404.0000 | 22,080,246 | 0.32% | 0.01% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | A | Stock Option (Right to Buy) | 1290 | $0.00 | 1,290.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | A | Common Stock | 715 | $0.00 | 842,704.0000 | 22,080,246 | 0.08% | 0.00% |
| June 12, 2025 | Prelude Therapeutics Inc | $PRLD | FRIEDMAN PAUL A | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | A | Common Stock | 714 | $0.00 | 841,989.0000 | 0 | 0.08% | 0.00% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Prelude Therapeutics Inc | $PRLD | FRIEDMAN PAUL A | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 3464 | $247.76 | 846,141.0000 | 0 | 0.41% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | M | Stock Option (Right to Buy) | 26270 | $0.00 | 206,256.0000 | 0 | 11.30% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 4866 | $248.59 | 841,275.0000 | 0 | 0.58% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 5028 | $246.96 | 849,605.0000 | 0 | 0.59% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 2078 | $245.71 | 854,633.0000 | 0 | 0.24% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 5663 | $244.86 | 856,711.0000 | 0 | 0.66% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 3730 | $244.12 | 862,374.0000 | 0 | 0.43% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | S | Common Stock | 1441 | $242.95 | 866,104.0000 | 0 | 0.17% | 0.00% |
| April 8, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | M | Common Stock | 26270 | $9.45 | 867,545.0000 | 0 | 3.12% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 9264 | $243.20 | 850,913.0000 | 0 | 1.08% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 612 | $241.15 | 866,856.0000 | 0 | 0.07% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1420 | $240.10 | 867,468.0000 | 0 | 0.16% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 27613 | $9.45 | 868,888.0000 | 0 | 3.28% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 200 | $248.43 | 841,275.0000 | 0 | 0.02% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 18806 | $245.34 | 843,096.0000 | 0 | 2.18% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1821 | $246.31 | 841,275.0000 | 0 | 0.22% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 18710 | $9.45 | 859,985.0000 | 0 | 2.22% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 6273 | $241.07 | 853,712.0000 | 0 | 0.73% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5299 | $242.25 | 848,413.0000 | 0 | 0.62% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1467 | $243.00 | 846,946.0000 | 0 | 0.17% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 627 | $244.31 | 846,319.0000 | 0 | 0.07% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2549 | $245.14 | 843,770.0000 | 0 | 0.30% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 1558 | $246.13 | 842,212.0000 | 0 | 0.18% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 6679 | $242.42 | 860,177.0000 | 0 | 0.77% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 27613 | $0.00 | 232,526.0000 | 0 | 10.61% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 18710 | $0.00 | 260,139.0000 | 0 | 6.71% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Stock Option (Right to Buy) | 27407 | $0.00 | 278,849.0000 | 0 | 8.95% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 444 | $245.92 | 841,275.0000 | 0 | 0.05% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 4301 | $244.58 | 861,902.0000 | 0 | 0.50% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 2294 | $243.64 | 866,203.0000 | 0 | 0.26% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 185 | $242.00 | 868,497.0000 | 0 | 0.02% | 0.00% |
| April 3, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | M | Common Stock | 27407 | $9.45 | 868,682.0000 | 0 | 3.26% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 5228 | $245.35 | 841,719.0000 | 0 | 0.62% | 0.00% |
| April 5, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 3966 | $244.22 | 846,947.0000 | 0 | 0.47% | 0.00% |
| April 4, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Director | S | Common Stock | 737 | $247.14 | 841,475.0000 | 0 | 0.09% | 0.00% |
| Jan. 16, 2023 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | FRIEDMAN PAUL A | Not found | F | Common Stock | 2254 | $243.92 | 841,275.0000 | 0 | 0.27% | 0.00% |